• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病患者肝素凝血酶凝血时间缩短、纤维蛋白原和血小板聚集计数增加:一种可能的高凝状态。

Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state.

作者信息

Patrassi G M, Toffanin F, Massa G, Schivazappa L, Girolami A

出版信息

Folia Haematol Int Mag Klin Morphol Blutforsch. 1979;106(3):414-25.

PMID:89993
Abstract

Several indices of plasmatic and platelet coagulability (H.T.C.T., AT III, fibrinogen and Wu-Hoak test) were studied in 82 patients with acute and chronic coronary artery disease. The results were compared with those obtained in a control group. The most interesting result is the consistent shortening of H.T.C.T. as compared to the control group, particularly in patients with acute myocardial infarction. H.T.C.T. was always inversely correlated with the fibrinogen level. Those data suggest an important influence of fibrinogen levels on H.T.C.T., but this observation does not rule out the possibility that the heparin neutralizing activity (PF 4) will also influence the test. No positive correlation between H.T.C.T. and AT III could be observed. The elevated levels of AT III in acute myocardial infarction did not confirm the existence of a consumption of AT III due to chronic intravascular coagulation in these patients. The Wu-Hoak test increased only in patients with acute coronary disease, never in the other groups. In conclusion, H.T.C.T. may be assumed to be a valid test for indicating the existence of a possible hypercoagulability state.

摘要

对82例急慢性冠状动脉疾病患者的多项血浆和血小板凝固性指标(血细胞比容、抗凝血酶III、纤维蛋白原和吴-霍克试验)进行了研究。将结果与对照组的结果进行了比较。最有趣的结果是,与对照组相比,血细胞比容持续缩短,尤其是急性心肌梗死患者。血细胞比容始终与纤维蛋白原水平呈负相关。这些数据表明纤维蛋白原水平对血细胞比容有重要影响,但这一观察结果并不排除肝素中和活性(PF 4)也会影响该试验的可能性。未观察到血细胞比容与抗凝血酶III之间存在正相关。急性心肌梗死患者抗凝血酶III水平升高并未证实这些患者因慢性血管内凝血而存在抗凝血酶III消耗的情况。吴-霍克试验仅在急性冠状动脉疾病患者中升高,在其他组中从未升高。总之,可以认为血细胞比容是一种有效的试验,用于指示可能存在的高凝状态。

相似文献

1
Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state.冠心病患者肝素凝血酶凝血时间缩短、纤维蛋白原和血小板聚集计数增加:一种可能的高凝状态。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1979;106(3):414-25.
2
Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.术前接受依诺肝素治疗的冠状动脉手术患者的肝素抵抗和血小板活化增加。
Eur J Cardiothorac Surg. 2006 Jun;29(6):933-40. doi: 10.1016/j.ejcts.2006.02.007. Epub 2006 May 3.
3
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.亚临床甲状腺疾病中的血液凝固、纤溶活性和血脂谱:亚临床甲状腺功能亢进会增加血浆凝血因子X活性。
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9. doi: 10.1111/j.1365-2265.2006.02464.x.
4
Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.幽门螺杆菌(H. pylori)感染与冠状动脉疾病:经皮冠状动脉腔内血管成形术后幽门螺杆菌根除对冠状动脉管腔的影响。人冠状动脉粥样硬化斑块中幽门螺杆菌特异性DNA的检测。
J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31.
5
Haemostatic function in coronary artery disease (CAD).冠状动脉疾病(CAD)中的止血功能。
Indian J Pathol Microbiol. 1997 Apr;40(2):133-7.
6
Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.通过凝血酶生成试验评估,急性冠状动脉疾病与慢性冠状动脉疾病相比,凝血酶生成增加。
Thromb Haemost. 2008 Feb;99(2):382-7. doi: 10.1160/TH07-07-0443.
7
Heparin neutralizing activity (HNA) and antithrombin III in coronary artery disease.冠状动脉疾病中的肝素中和活性(HNA)与抗凝血酶III
Thromb Haemost. 1977 Oct 31;38(3):696-700.
8
Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia.II型高脂蛋白血症患者血浆纤维蛋白原和血小板聚集体增加。
Thromb Haemost. 1980 Feb 29;42(5):1503-7.
9
Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.冠状动脉搭桥术中原发性和继发性止血的围手术期监测
Semin Thromb Hemost. 2005;31(4):426-40. doi: 10.1055/s-2005-916678.
10
Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.评估C反应蛋白、纤维蛋白原和抗凝血酶III作为冠状动脉疾病的危险因素。
Isr Med Assoc J. 2001 Jan;3(1):13-6.